Recordati SpA (FRA:RER1) Days Sales Outstanding : 75.18 (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Recordati SpA Days Sales Outstanding?

Recordati SpA's average Accounts Receivable for the three months ended in Dec. 2023 was €433 Mil. Recordati SpA's Revenue for the three months ended in Dec. 2023 was €526 Mil. Hence, Recordati SpA's Days Sales Outstanding for the three months ended in Dec. 2023 was 75.18.

The historical rank and industry rank for Recordati SpA's Days Sales Outstanding or its related term are showing as below:

FRA:RER1' s Days Sales Outstanding Range Over the Past 10 Years
Min: 60.61 Med: 66.22 Max: 71.28
Current: 70.74

During the past 13 years, Recordati SpA's highest Days Sales Outstanding was 71.28. The lowest was 60.61. And the median was 66.22.

FRA:RER1's Days Sales Outstanding is ranked better than
51.2% of 998 companies
in the Drug Manufacturers industry
Industry Median: 72.035 vs FRA:RER1: 70.74

Recordati SpA's Days Sales Outstanding increased from Dec. 2022 (72.44) to Dec. 2023 (75.18).

Recordati SpA Days Sales Outstanding Historical Data

The historical data trend for Recordati SpA's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Days Sales Outstanding Chart

Recordati SpA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

66.84

71.28

66.61

65.94

70.74

Recordati SpA Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															66.32	78.10	73.62	75.18	66.84

Competitive Comparison of Recordati SpA's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Recordati SpA's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Recordati SpA's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Days Sales Outstanding falls into.

Recordati SpA Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Recordati SpA's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (361.898	+	445.193)	/	2 )	/	2082.331	*	365
=	403.5455					/	2082.331	*	365
=	70.74

Recordati SpA's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (421.755	+	445.193)	/	2 )	/	526.157	*	365 / 4
=	433.474					/	526.157	*	365 / 4
=	75.18

Recordati SpA (FRA:RER1) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Recordati SpA Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Recordati SpA (FRA:RER1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

RICFY:USA REC:Italy RECm:UK 0KBS:UK

Address

Via Matteo Civitali 1, MIlan, ITA, 20148

Website

https://www.recordati.com

Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (FRA:RER1) Headlines

No Headlines